Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBrief Communication

Cross-Linked Polyethylene Glycol Beads to Separate 99mTc-Pertechnetate from Low-Specific-Activity Molybdenum

François Bénard, Stefan K. Zeisler, Milan Vuckovic, Kuo-Shyan Lin, Zhengxing Zhang, Nadine Colpo, Xinchi Hou, Thomas J. Ruth and Paul Schaffer
Journal of Nuclear Medicine November 2014, 55 (11) 1910-1914; DOI: https://doi.org/10.2967/jnumed.114.143834
François Bénard
1BC Cancer Agency, Vancouver, British Columbia, Canada
2Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan K. Zeisler
3TRIUMF, Vancouver, British Columbia, Canada; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Milan Vuckovic
1BC Cancer Agency, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kuo-Shyan Lin
1BC Cancer Agency, Vancouver, British Columbia, Canada
2Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhengxing Zhang
1BC Cancer Agency, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nadine Colpo
1BC Cancer Agency, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xinchi Hou
4Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas J. Ruth
1BC Cancer Agency, Vancouver, British Columbia, Canada
3TRIUMF, Vancouver, British Columbia, Canada; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Schaffer
2Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada
3TRIUMF, Vancouver, British Columbia, Canada; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

We report a kit-based approach for the purification of sodium pertechnetate (99mTcO4−) from solutions with high MoO42− content. Methods: Cross-linked polyethylene glycol resins (ChemMatrix) were used to separate 99mTc and molybdenum in 4N NaOH. The resins were loaded at various flow rates and eluted with water to release 99mTc. The 99mTc solution was passed through a cation exchange resin and an alumina cartridge, followed by saline elution. This process was tested with cyclotron-produced 99mTc using an automated system and disposable kits. Results: Optimal results were obtained by loading 500 mg of resin at flow rates of up to 3.1 mL/min, with quantitative extraction of 99mTc from the molybdate solution and complete release of 99mTc after elution with water. The automated system was highly efficient at isolating Na99mTcO4 within minutes, with a recovery rate of 92.7% ± 1.1% (mean ± SD) using cyclotron-produced 99mTc. Conclusion: ChemMatrix resins were highly effective at separating 99mTcO4− from molybdate solutions.

  • 99mTc-pertechnetate
  • molybdenum
  • generators

The radioisotope 99mTc is typically obtained from 99Mo/99mTc generators made with a small alumina cartridge on which radioactive 99Mo is immobilized as 99MoO42−. High-specific-activity 99Mo is required because of the limited binding capacity of alumina (1,2). However, most research reactors used for radioisotope production are facing obsolescence, and supply disruptions have become more common. Alternative production methods have been proposed to secure the supply of 99mTc, such as direct production by cyclotrons (3) and production of 99Mo by linear accelerators or neutron enrichment of 98Mo (4). These approaches lead to high amounts of molybdenum present in the final target dissolution mixture.

The use of biphasic separation was reported for the extraction of 99Tc from nuclear waste eluents (5) and later was implemented in a generator system (6). This approach used polyethylene glycol (PEG) chains grafted onto polystyrene particles to enable separation on solid support. We recently reported a similar approach for the purification of cyclotron-produced 99mTc (7).

PEG-grafted polystyrene resins have long been used for the solid-phase synthesis of lengthy, difficult peptides. To overcome some limitations of polystyrene-based resins, cross-linked PEG-only resins were developed for solid-phase peptide synthesis (8). These resins are reported to have high loading capacity, high swelling, broad solvent compatibility, and chemical resistance. Because these beads maintain a high number of PEG sites, we hypothesized that this material would be effective for separating 99mTc from 99MoO42− on the basis of the established propensity for 99mTcO4− to favorably associate with PEG moieties under high dielectric potential (9).

MATERIALS AND METHODS

PEG-Only Resins

A series of cross-linked PEG resins, originally developed for solid-phase synthesis of long peptides, was used for this project. All were based on ChemMatrix resins (PCAS Biomatrix). Aminomethyl and Wang (p-alkoxybenzyl alcohol) resins were purchased from the manufacturer. Nitrile resins were obtained from PCAS Biomatrix as research samples and were also available as a special order from the supplier.

The structures of resins are shown in Figure 1, with aminomethyl-ChemMatrix as structure 1. The acetyl resin (structure 2) was prepared by incubating aminomethyl resin (1.68 g) with 10 equivalents of acetic anhydride and 10 equivalents of N,N-diisopropylethylamine in methylene chloride (30 mL) at ambient temperature for 48 h. The mesyl resin was synthesized by reacting 2.0 g of structure 1 with 5 equivalents of methane sulfonyl chloride and 5 equivalents of N,N-diisopropylethylamine in methylene chloride (60 mL) at ambient temperature for 4 d to obtain derivative 3. tert-butyloxycarbonyl (BOC)-ChemMatrix was prepared by reacting 1 (2.0 g) with 5 equivalents of di-tert-butyl dicarbonate and 5 equivalents of N,N-diisopropylethylamine in methanol (60 mL) at ambient temperature for 4 d to obtain structure 4. PEGylated ChemMatrix was prepared by reacting 1.5 g of structure 1 with poly(ethylene glycol) methyl ether tosylate (average molecular weight, 2,000) and 2 equivalents of potassium carbonate in acetonitrile (30 mL) under reflux for 6 d. After dilution of the reaction mixture with water (30 mL), the PEG-ChemMatrix resin (derivative 5) was recovered.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Structures of various ChemMatrix resins tested for 99mTc purification. Structure 1 is aminomethyl-ChemMatrix, structure 2 is acetyl-ChemMatrix, structure 3 is mesyl-ChemMatrix, structure 4 is BOC-ChemMatrix, structure 5 is PEG-ChemMatrix, and structure 6 is nitrile-ChemMatrix.

All resins were recovered by filtration, washed twice with 20 mL of N-methylpyrrolidinone, methanol, and N-methylpyrrolidinone followed by 3 × 20 mL of methylene chloride and methanol and then dried under a vacuum before use.

Optimization of Separation Conditions

The 99mTc/molybdate separation conditions were established to replicate the composition of an irradiated 100Mo cyclotron target. Briefly, 1.5–2.0 g of molybdenum metal powder were dissolved in 20 mL of 30% H2O2, 99mTc was added to the solution, and 8 M NaOH was added slowly to obtain a mixture of 99mTc and molybdenum oxides in a final concentration of 4N NaOH. The resins were loaded using a syringe pump (Harvard Apparatus) at flow rates from 0.5 to 2.0 mL/min. The resins were eluted with distilled, deionized water at flow rates ranging from 0.5 to 10 mL/min to release 99mTc. The activity was assayed in a vial before loading on resin, after trapping on resin, and after elution with water. The loading percentage was calculated as the activity on resin divided by the total activity (waste + resin). The elution percentage was calculated as the percentage activity recovered divided by the total activity (eluent + resin). The total net percentage yield was calculated as the activity recovered divided by the total activity (waste + resin + eluent).

Disposable Kits for Automated Purification

This purification process was implemented for cyclotron production of 99mTc on a compact commercial automated synthesizer, which uses disposable kits (miniAIO; Trasis). The kits were constituted of U.S. Pharmacopeia grade VI plastics, with 1/16-in (1.6-mm)-diameter silicon tubing (Tygon), polypropylene barbed connectors, and Luer adapters, as well as standard disposable syringes. A 4-mL solid-phase separation reservoir with a frit at the bottom (United Chemical Technologies) was used to hold the resin. A strong cation exchange resin (OnGuard II H Cartridge; Dionex) was used to neutralize the solution eluted from the ChemMatrix resin. An alumina cartridge (Sep-Pak Alumina A Plus Light Cartridge; Waters) was used to remove potential traces of molybdenum and trap 99mTc for dispensing into 0.9% sodium chloride solution. A photograph of a disposable kit assembled on the automated synthesis unit is shown in Figure 2.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

Picture of automated synthesis unit equipped with disposable kit for purification of 99mTc-pertechnetate. The 2 syringes at top are initially filled with water (H2O) and 4N sodium hydroxide (NaOH). ChemMatrix resin is indicated with red arrow. Cation exchange resin is indicated with yellow arrow. Alumina cartridge location is indicated with green arrow.

Procedure for 99mTc Automated Purification

99mTc was separated using a modification of aqueous biphasic extraction procedures reported elsewhere (7). The process flow is illustrated in Figure 3. Briefly, the ChemMatrix resin was preconditioned with 5 mL of 4N NaOH. The cation exchange resin and alumina cartridges were rinsed and preconditioned with 3 mL of water. The 99mTc/molybdate crude dissolution mixture (75 mL) in 4N NaOH was loaded at flow rates of 2.6–3.1 mL/min onto the resin. During this step, all the liquid that passed through the resin went to a waste vial, to recover molybdenum for recycling or reuse. The resin was washed with 4 mL of 4N NaOH, purged with nitrogen gas, and eluted with 10 mL of water at a rate of 2 mL/min. The eluent was passed through the cation exchange resin and the alumina columns connected in series. The cartridges were rinsed with water, and the alumina column was eluted with 10 mL of normal saline through a 0.22-μm sterile filter (Millex-GS; Millipore) for recovery of Na99mTcO4 into a final product vial. The process was completed in 41–46 min. A screen capture of the control software is shown in Figure 4.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

Diagram summarizing automated purification process.

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

Screen capture of user-defined layout of control screen, at start of purification process, highlighting relationship of various rotary actuators and syringes operating disposable kit components (adapted from Trasis base layout).

Testing Using Cyclotron-Produced 99mTc

Three 99mTc production runs were performed following procedures previously described (10), with an irradiation time of 1–1.5 h at a beam current of 100 μA. The targets were dissolved in 10% H2O2. 99mTc-pertechnetate was purified using the automated system described above.

Quality Control and Kit Radiolabeling

The Na99mTcO4 solution was tested for alumina by a colorimetric test kit (Biodex). Hydrolyzed reduced 99mTc was evaluated by thin-layer paper chromatography using Whatman paper, developed in acetone. Kits for neutral (99mTc-exametazime; GE Healthcare), cationic (99mTc-tetrofosmin; GE Healthcare), and anionic (99mTc-medronate; DraxImage) radiopharmaceuticals were reconstituted and tested according to the manufacturer’s instructions.

Determination of Radionuclidic Purity

Radionuclidic purity of the final product was measured on a high-purity germanium γ-ray spectrometer (Canberra), calibrated using a multinuclide National Institute of Standards and Technology traceable radioactive standard (Eckert and Ziegler). When necessary, radioactive samples were diluted to ensure that detector dead time was less than 5%. All samples used the same geometry as the multinuclide standard source. Measurements of the final product after end-of-beam were taken at 3 and 24 h, at 6–7 d, and in some cases after 30 d. Measurements of the waste vials were taken 4–6 h after end-of-beam.

RESULTS

We observed significant differences in the volume of the ChemMatrix resins in 4N NaOH compared with water. In 4N NaOH, the individual beads were smaller, and particle size increased 2- or 3-fold in water (Fig. 5).

FIGURE 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 5.

Microscopic images of ChemMatrix resin loaded on hemocytometer. Beads are significantly smaller in high-salt solutions such as 4 M NaOH (A) than in water (B).

The results of the separation experiments are shown in Table 1. Incomplete trapping was noted with the aminomethyl and acetyl ChemMatrix resins when 300 mg were used at flow rates of 1 mL/min or higher. Increasing the quantity of resin to 500 mg led to near-quantitative (97%–100%) trapping of 99mTc with all resins, while allowing higher flow rates. Although adequate release was observed when 300 mg of aminomethyl resin were used, elution was less efficient (69%–85%) when higher quantities (>500 mg) of resin were used. All resins with other terminal groups, such as mesyl, acetyl, BOC, Wang, or nitrile, were effective at trapping and releasing 99mTc, with complete or nearly complete trapping and elution.

View this table:
  • View inline
  • View popup
TABLE 1

Results of Separation Experiments

The automated system with disposable cassettes was highly efficient at isolating cyclotron-produced 99mTc within minutes, with a recovery rate of 92.7% ± 1.1% (mean ± SD; range, 91.5%–93.5%). Minimal losses occurred, with some 99mTc being recovered in waste (6.6% ± 1.1%) or trapped on the resin (0.19% ± 0.02%), the alumina cartridge (0.59% ± 0.12%), or the cation exchange resin (0.014% ± 0.003%). Less than 1% of the initial activity remained in disposable syringes or lines used in the purification module. No aluminum was detected in the final product. All reconstituted kits passed quality control tests recommended by the manufacturer (Table 2). Decay-corrected to end-of-beam, the radionuclidic purity was 99.940% ± 0.004% (average percentage of total purified activity with SD; n = 3 production runs). Only traces of other technetium radioisotopes (97mTc, 0.003% ± 0.004%; 96gTc, 0.002% ± 0.001%; 95mTc, <0.0001%; 95gTc, 0.009% ± 0.005%; 94mTc, 0.044% ± 0.012%; 94gTc, 0.012% ± 0.004%; 93gTc, 0.007% ± 0.004%) were present in the 99mTc-pertechnetate. Other radioactive species known to be coproduced during proton irradiation of 100Mo (7,11), notably radioactive niobium and molybdenum radioisotopes, were not detected in the final product samples but were found in the waste recovery vessel. These radioisotopes included 99Mo (0.78% ± 0.42%; average percentage of total activity produced with SD; n = 3 production runs), 96Nb (0.06% ± 0.03%), and 97Nb (4.0% ± 2.9%).

View this table:
  • View inline
  • View popup
TABLE 2

Results of Quality Control Testing

DISCUSSION

Methods developed to separate 99mTc from 99Mo were recently reviewed by Dash et al. (12). In this study, we showed that ChemMatrix resins were efficient at selectively trapping 99mTc without retaining molybdenum in the presence of 4N NaOH, with quantitative elution using water. The overall Na99mTcO4 purification was implemented using a compact commercial automated synthesis system designed for use with disposable kits. We achieved high trapping efficiency with reproducible results using cyclotron-produced 99mTc. It should be noted that as the counts in the waste solution were not corrected for the presence of isotope contaminants that are known to occur with cyclotron-produced technetium (such as 99Mo and 95Nb) and were effectively separated from 99mTc, the recovery percentage of 99mTc was likely slightly underestimated. Because of the experimental design using cyclotron-produced pertechnetate, we did not evaluate the fraction of molybdenum recovered in the waste vial after technetium extraction by the ChemMatrix resin. Although molybdenum is not retained in high-pH, high-salt solutions by biphasic exchange chromatography, the determination of precise recovery yields will require further studies by testing this system with low-specific-activity 99Mo solutions that are quantified before and after purification.

The entire process is amenable to meeting good manufacturing practice–compliant production. This method is applicable for separation of 99mTcO4− from any solution containing excess molybdate ions and should be suitable for use with low-specific-activity 99Mo, with minor modifications to recirculate the 99Mo solution for daily reuse.

CONCLUSION

Cross-linked PEG beads were highly effective at separating and purifying 99mTc from low-specific-activity molybdate solutions, with quantitative trapping and elution of 99mTc. 99mTc-pertechnetate was purified in high yields using a simple disposable kit system.

DISCLOSURE

The costs of publication of this article were defrayed in part by the payment of page charges. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 USC section 1734. This work was supported by the Natural Sciences and Engineering Research Council, the Canadian Institutes of Health Research, and Natural Resources Canada. A provisional application for a patent was filed for some of the material presented in this article. No other potential conflict of interest relevant to this article was reported.

Footnotes

  • Published online Oct. 20, 2014.

  • © 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

REFERENCES

  1. 1.↵
    1. Asif M,
    2. Mushtaq A
    . Evaluation of highly loaded low specific activity Mo-99 on alumina column as Tc-99m generator. J Radioanal Nucl Chem. 2010;284:439–442.
    OpenUrlCrossRef
  2. 2.↵
    1. Chattopadhyay S,
    2. Das SS,
    3. Das MK,
    4. Goomer NC
    . Recovery of 99mTc from Na2[99Mo]MoO4 solution obtained from reactor-produced (n,gamma) 99Mo using a tiny Dowex-1 column in tandem with a small alumina column. Appl Radiat Isot. 2008;66:1814–1817.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Beaver JE,
    2. Hupf HB
    . Production of 99mTc on a medical cyclotron: a feasibility study. J Nucl Med. 1971;12:739–741.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Pillai MR,
    2. Dash A,
    3. Knapp FF Jr.
    . Sustained availability of 99mTc: possible paths forward. J Nucl Med. 2013;54:313–323.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Rogers RD,
    2. Zhang J
    . Effects of increasing polymer hydrophobicity on distribution ratios of TcO4- in polyethylene/poly(propylene glycol)-based aqueous biphasic systems. J Chromatogr B Biomed Appl. 1996;680:231–236.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. McAlister DR,
    2. Philip Horwitz E
    . Automated two column generator systems for medical radionuclides. Appl Radiat Isot. 2009;67:1985–1991.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Morley TJ,
    2. Dodd M,
    3. Gagnon K,
    4. et al
    . An automated module for the separation and purification of cyclotron-produced 99mTcO4. Nucl Med Biol. 2012;39:551–559.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. García-Martin F,
    2. Quintanar-Audelo M,
    3. Garcia-Ramos Y,
    4. et al
    . ChemMatrix, a poly(ethylene glycol)-based support for the solid-phase synthesis of complex peptides. J Comb Chem. 2006;8:213–220.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Hatti-Kaul R
    1. Huddleston J,
    2. Griffin S,
    3. Zhang J,
    4. Willauer H,
    5. Rogers R
    . Metal ion separations in aqueous biphasic systems and with ABEC resins. In: Hatti-Kaul R, ed. Aqueous Two-Phase Systems: Methods and Protocols. Totowa, NJ: Humana Press; 2000:77–94.
  10. 10.↵
    1. Bénard F,
    2. Buckley KR,
    3. Ruth TJ,
    4. et al
    . Implementation of multi-curie production of 99mTc by conventional medical cyclotrons. J Nucl Med. 2014;55:1017–1022.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Celler A,
    2. Hou X,
    3. Benard F,
    4. Ruth T
    . Theoretical modeling of yields for proton-induced reactions on natural and enriched molybdenum targets. Phys Med Biol. 2011;56:5469–5484.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Dash A,
    2. Knapp FF Jr.,
    3. Pillai MR
    . 99Mo/99mTc separation: an assessment of technology options. Nucl Med Biol. 2013;40:167–176.
    OpenUrlCrossRefPubMed
  • Received for publication May 27, 2014.
  • Accepted for publication September 17, 2014.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 55 (11)
Journal of Nuclear Medicine
Vol. 55, Issue 11
November 1, 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cross-Linked Polyethylene Glycol Beads to Separate 99mTc-Pertechnetate from Low-Specific-Activity Molybdenum
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Cross-Linked Polyethylene Glycol Beads to Separate 99mTc-Pertechnetate from Low-Specific-Activity Molybdenum
François Bénard, Stefan K. Zeisler, Milan Vuckovic, Kuo-Shyan Lin, Zhengxing Zhang, Nadine Colpo, Xinchi Hou, Thomas J. Ruth, Paul Schaffer
Journal of Nuclear Medicine Nov 2014, 55 (11) 1910-1914; DOI: 10.2967/jnumed.114.143834

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cross-Linked Polyethylene Glycol Beads to Separate 99mTc-Pertechnetate from Low-Specific-Activity Molybdenum
François Bénard, Stefan K. Zeisler, Milan Vuckovic, Kuo-Shyan Lin, Zhengxing Zhang, Nadine Colpo, Xinchi Hou, Thomas J. Ruth, Paul Schaffer
Journal of Nuclear Medicine Nov 2014, 55 (11) 1910-1914; DOI: 10.2967/jnumed.114.143834
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Clinical Trial with Sodium 99mTc-Pertechnetate Produced by a Medium-Energy Cyclotron: Biodistribution and Safety Assessment in Patients with Abnormal Thyroid Function
  • Radioisotopic Purity of Sodium Pertechnetate 99mTc Produced with a Medium-Energy Cyclotron: Implications for Internal Radiation Dose, Image Quality, and Release Specifications
  • Google Scholar

More in this TOC Section

  • Feasibility of Short-Term Redifferentiation in Patients with Radioactive Iodine–Refractory Metastatic Thyroid Cancer
  • First-in-Human Serum Stability Studies of [177Lu]Lu-AMTG: A Step Toward Improved GRPR-Targeted Radiopharmaceutical Therapy
  • Initial Experience with Dual-Time-Point [18F]Flurpiridaz PET/CT for Localization of Parathyroid Adenomas in Primary Hyperparathyroidism
Show more Brief Communication

Similar Articles

Keywords

  • 99mTc-pertechnetate
  • molybdenum
  • generators
SNMMI

© 2025 SNMMI

Powered by HighWire